STAT3 and cancer: Mitochondrial function and STAT3 are intricately linked, and recently two novel STAT3 inhibitors, OPB-51602 and OPB-111077, were found to be inhibitors of mitochondrial oxidative phosphorylation and able to resensitize cancer cells to tyrosine kinase inhibitors [8,56].